GNLX Form 4: 10,000 RSUs granted and 8,333 options repriced on 09/01/2025
Rhea-AI Filing Summary
Genelux Corp (GNLX) reporting person Ralph Smalling received 10,000 restricted stock units that vest over time and had option activity effective 09/01/2025. The RSUs vest 25% after one year and then in 12 equal quarterly installments. An existing option for 8,333 shares with a $6.00 exercise price was replaced by an option covering 8,333 shares with a reduced exercise price of $3.33 effective 09/01/2025; vesting and expiration (09/23/2030) remain unchanged. Following the transactions, Mr. Smalling beneficially owned 70,990 shares and held 8,333 exercisable options.
Positive
- 10,000 RSUs granted under the 2022 Equity Incentive Plan with a clear vesting schedule
- Exercise price reduced to $3.33 for 8,333 options effective 09/01/2025 with no change to vesting or expiration
- Beneficial ownership reported at 70,990 shares following the reported transactions
Negative
- None.
Insights
TL;DR: Insider received RSUs and had an option repriced to market, with vesting schedules preserved.
The filing discloses a compensation-related equity grant and an adjustment to an outstanding option's exercise price that aligns the strike with the market price on 09/01/2025. The RSU grant establishes time-based retention through scheduled vesting. The option adjustment did not alter expiration or vesting, indicating a mechanical repricing rather than a new grant. These actions are routine for executive compensation but are material to insider alignment with shareholder interests because they change potential future dilution timing and strike economics.
TL;DR: Director/officer adds 10,000 RSUs and holds 8,333 re-priced options; total beneficial ownership now 70,990 shares.
The report shows acquisition of 10,000 RSUs and conversion of an option position such that 8,333 options now carry a $3.33 exercise price effective 09/01/2025 with an unchanged 09/23/2030 expiration and original vesting schedule. The filing also notes a disposal/adjustment of the prior $6.00 option. The disclosed holdings and changes are specific and verifiable from the filing and are notable for modeling potential future share issuance upon vesting or exercise.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Stock Option (Right to Buy) | 8,333 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 8,333 | $0.00 | -- |
| Grant/Award | Common Stock | 10,000 | $0.00 | -- |
Footnotes (1)
- Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common Stock upon vesting. The RSUs will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 12 equal quarterly (every 3 months) installments thereafter. The shares subject to the option vest as follows: 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter. The transactions reported herein reflect a one-time reduction of the exercise price of the stock option, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration date or the vesting schedule of the stock option.
